: Priced around $1.28, KULR focuses on battery safety and thermal management for tech and aerospace.
: Offers a 3.4% dividend yield (3x the S&P 500 average) and is considered undervalued after acquisition expenses temporary depressed earnings.
: Trading around $4.03, this biotech firm has a forward P/E of 3.00. It is a high-growth play with projected 1-year EPS growth of over 150%.
: Priced around $1.28, KULR focuses on battery safety and thermal management for tech and aerospace.
: Offers a 3.4% dividend yield (3x the S&P 500 average) and is considered undervalued after acquisition expenses temporary depressed earnings.
: Trading around $4.03, this biotech firm has a forward P/E of 3.00. It is a high-growth play with projected 1-year EPS growth of over 150%.